[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: EG009A Manufactured by: Frontage Laboratories; Inc. USA: Dose: 500 mg/2 mL;Frequency: Loading doses (Days 1-3) 500 mg/2mL BID & Maintenance doses (days 8; 12; 15; 19; 22; 26) EG009A 500 mg/2mL;Route of administration: IM;Duration of Therapy: 29 DaysControl Intervention1: EG009A Placebo Manufactured by: Frontage Laboratories; Inc. USA: Dose: 0 mg/mL;Frequency: Loading doses (Days 1-3) 2mL BID & Maintenance doses (days 8; 12; 15; 19; 22; 26) EG009A Placebo 2mL;Route of administration: IM;Duration of Therapy: 29 Days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: EG009A Manufactured by: Frontage Laboratories; Inc. USA: Dose: 500 mg/2 mL;Frequency: Loading doses (Days 1-3) 500 mg/2mL BID & Maintenance doses (days 8; 12; 15; 19; 22; 26) EG009A 500 mg/2mL;Route of administration: IM;Duration of Therapy: 29 Days", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: EG009A Placebo Manufactured by: Frontage Laboratories; Inc. USA: Dose: 0 mg/mL;Frequency: Loading doses (Days 1-3) 2mL BID & Maintenance doses (days 8; 12; 15; 19; 22; 26) EG009A Placebo 2mL;Route of administration: IM;Duration of Therapy: 29 Days", "treatment_type": "Placebo", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1906, "treatment_name": "Eg-009a", "treatment_type": "Anti-inflammatories", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]